Your browser doesn't support javascript.
loading
Intronic TP53 Polymorphisms Are Associated with Increased Δ133TP53 Transcript, Immune Infiltration and Cancer Risk.
Eiholzer, Ramona A; Mehta, Sunali; Kazantseva, Marina; Drummond, Catherine J; McKinney, Cushla; Young, Katie; Slater, David; Morten, Brianna C; Avery-Kiejda, Kelly A; Lasham, Annette; Fleming, Nicholas; Morrin, Helen R; Reader, Karen; Royds, Janice A; Landmann, Michael; Petrich, Simone; Reddel, Roger; Huschtscha, Lily; Taha, Ahmad; Hung, Noelyn A; Slatter, Tania L; Braithwaite, Antony W.
Afiliação
  • Eiholzer RA; Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.
  • Mehta S; Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.
  • Kazantseva M; Maurice Wilkins Centre for Molecular Biodiscovery, Dunedin 9016, New Zealand.
  • Drummond CJ; Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.
  • McKinney C; Maurice Wilkins Centre for Molecular Biodiscovery, Dunedin 9016, New Zealand.
  • Young K; Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.
  • Slater D; Maurice Wilkins Centre for Molecular Biodiscovery, Dunedin 9016, New Zealand.
  • Morten BC; Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.
  • Avery-Kiejda KA; Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.
  • Lasham A; Priority Research Centre for Cancer Research, Innovation and Translation and the Hunter Cancer Research Alliance, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, New South Wales 2305, Australia.
  • Fleming N; Hunter Medical Research Institute, New South Wales 2305, Australia.
  • Morrin HR; Priority Research Centre for Cancer Research, Innovation and Translation and the Hunter Cancer Research Alliance, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, New South Wales 2305, Australia.
  • Reader K; Hunter Medical Research Institute, New South Wales 2305, Australia.
  • Royds JA; Priority Research Centre for Cancer Research, Innovation and Translation and the Hunter Cancer Research Alliance, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, New South Wales 2305, Australia.
  • Landmann M; Hunter Medical Research Institute, New South Wales 2305, Australia.
  • Petrich S; Department of Molecular Medicine and Pathology, University of Auckland, Auckland 1023, New Zealand.
  • Reddel R; Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.
  • Huschtscha L; Department of Pathology and Biomedical Science, University of Otago, Christchurch 8140, New Zealand.
  • Taha A; Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.
  • Hung NA; Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.
  • Slatter TL; Department of Surgical Sciences, Dunedin School of Medicine, University of Otago, Dunedin 9054, New Zealand.
  • Braithwaite AW; Department of Surgical Sciences, Dunedin School of Medicine, University of Otago, Dunedin 9054, New Zealand.
Cancers (Basel) ; 12(9)2020 Sep 01.
Article em En | MEDLINE | ID: mdl-32882831
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Nova Zelândia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Nova Zelândia